Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Blood Coagulation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06700096
What this trial is testing

An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B

Who this might be right for
Hemophilia B
Biocad 24
Not applicableStudy completedNCT00705991
What this trial is testing

Validation of Thrombelastometry (ROTEM®)

Who this might be right for
Coagulation
University of Zurich
Large-scale testing (Phase 3)Study completedNCT00616460
What this trial is testing

ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for Bleeding

Who this might be right for
Hematologic Diseases
HaEmek Medical Center, Israel 100
Very early researchStudy completedNCT05281718
What this trial is testing

Factor IX as Adjunctive Therapy to Emicizumab (EMIX)

Who this might be right for
Hemophilia A
Tulane University 12
Testing effectiveness (Phase 2)Study completedNCT00441090
What this trial is testing

Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Chronic Idiopathic Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Idiopathic
Eisai Inc. 64
Early research (Phase 1)Active Not RecruitingNCT05936359
What this trial is testing

Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasms
Incyte Corporation 160
Not applicableStudy completedNCT02049099
What this trial is testing

A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care

Who this might be right for
Haemophilia AHaemophilia B
Swedish Orphan Biovitrum 1,658
Not applicableStudy completedNCT04265508
What this trial is testing

Assessment of Hemostatic Profile in Liver Cirrhosis

Who this might be right for
Coagulation Disorder
Goethe University 67
Not applicableUnknownNCT06312852
What this trial is testing

Impact of Antenatal Steroids on Coagulation.

Who this might be right for
Corticosteroids Adverse Reaction
Assiut University 45
Early research (Phase 1)Study completedNCT00774358
What this trial is testing

Interleukin-2 Treatment for Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome (WAS)X-linked Thrombocytopenia
Soma Jyonouchi 9
Large-scale testing (Phase 3)Study completedNCT00006348
What this trial is testing

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Alliance for Clinical Trials in Oncology 100
Not applicableEnrolling By InvitationNCT04574076
What this trial is testing

A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®

Who this might be right for
Haemophilia A
Novo Nordisk A/S 60
Not applicableUnknownNCT05506033
What this trial is testing

Optimization of Glucocorticoid Taper Strategies for SLE-ITP

Who this might be right for
Lupus Erythematosus, SystemicPurpura, Thrombocytopenic, IdiopathicGlucocorticoids+1 more
Fujian Medical University Union Hospital 120
Not applicableUnknownNCT06104826
What this trial is testing

Health-Related Quality of Life Outcomes and Bleeding Rates Among Patients With Severe Hemophilia A on Emicizumab

Who this might be right for
Hemophilia A
Newark Beth Israel Medical Center 50
Not applicableStudy completedNCT04971252
What this trial is testing

Type 2 Diabetes Mellitus and Chronic Kidney Disease

Who this might be right for
Renal Disorder Associated With Type II Diabetes Mellitus
Sohag University 150
Large-scale testing (Phase 3)Study completedNCT00157040
What this trial is testing

Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 50
Not applicableStudy completedNCT00932555
What this trial is testing

EffeKt Taiwan- Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Taiwan

Who this might be right for
Hemophilia A
Bayer 82
Testing effectiveness (Phase 2)Ended earlyNCT01897792
What this trial is testing

Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe Trauma

Who this might be right for
CoagulopathyNosocomial Pneumonia
University of Alabama at Birmingham 11
Not applicableStudy completedNCT01953016
What this trial is testing

Participation in a Research Registry for Immune Disorders

Who this might be right for
Primary ImmunodeficienciesAPECEDCGD+2 more
National Human Genome Research Institute (NHGRI) 716
Not applicableLooking for participantsNCT05004233
What this trial is testing

Transmission Electron Microscopy Images for Platelet Ultrastructural Criteria Before and After the Onset of an Antiplatelet Agent

Who this might be right for
Ischemic Stroke
Centre Hospitalier Universitaire de Saint Etienne 50
Next Page